WOBURN, Mass.--(BUSINESS WIRE)--March 21, 2006--BioTrove, Inc. and Blue Sky Biotech, Inc. announce a collaborative effort to provide a unique service solution, utilizing mass spectrometry-based high-throughput screening assays on previously unscreenable drug targets. Blue Sky will provide pharma-grade proteins that pharmaceutical companies can quickly screen against their entire small molecule libraries. BioTrove will utilize its proprietary RapidFire(TM) screening technology that has successfully screened millions of compounds.
